英国G群链球菌引起的链球菌中毒性休克综合征
Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
作者信息
Baxter Melissa, Morgan Marina
出版信息
Emerg Infect Dis. 2017 Jan;23(1):127-129. doi: 10.3201/eid2301.161009.
Abstract
We describe successful management of 3 patients with streptococcal toxic shock syndrome (STSS) attributable to group G Streptococcus infection. This small series supports recognition of group G Streptococcus in the etiology of STSS. We propose intravenous immunoglobulin be used in treatment as it is for STSS caused by group A Streptococcus.
摘要
我们描述了3例由G组链球菌感染引起的链球菌中毒性休克综合征（STSS）患者的成功治疗。这个小系列病例支持在STSS病因中识别G组链球菌。我们建议将静脉注射免疫球蛋白用于治疗，就像用于治疗由A组链球菌引起的STSS一样。
相似文献
1
Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
Emerg Infect Dis. 2017 Jan;23(1):127-129. doi: 10.3201/eid2301.161009.
2
Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Clin Infect Dis. 2014 Sep 15;59(6):851-7. doi: 10.1093/cid/ciu449. Epub 2014 Jun 13.
3
A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis.
J Infect Chemother. 2012 Dec;18(6):919-24. doi: 10.1007/s10156-012-0375-x. Epub 2012 Feb 11.
4
Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases.
J Infect Chemother. 2019 May;25(5):355-361. doi: 10.1016/j.jiac.2019.01.006. Epub 2019 Feb 7.
5
Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.
Scand J Infect Dis. 2005;37(3):166-72. doi: 10.1080/00365540410020866.
6
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
J Antimicrob Chemother. 2006 Jul;58(1):117-24. doi: 10.1093/jac/dkl173. Epub 2006 May 2.
7
Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited.
Emerg Infect Dis. 2017 Jan;23(1):150-152. doi: 10.3201/eid2301.161063.
8
Toxic shock syndrome and streptococcal myositis: three case reports.
Eur J Pediatr. 2002 Sep;161(9):497-8. doi: 10.1007/s00431-002-1032-7. Epub 2002 Aug 13.
9
Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
Int J Infect Dis. 2010 Sep;14 Suppl 3:e208-12. doi: 10.1016/j.ijid.2009.07.014. Epub 2009 Nov 13.
10
Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
Clin Infect Dis. 2014 Aug 1;59(3):358-65. doi: 10.1093/cid/ciu304. Epub 2014 Apr 29.
引用本文的文献
1
subsp. infection and its intersection with .
Clin Microbiol Rev. 2024 Sep 12;37(3):e0017523. doi: 10.1128/cmr.00175-23. Epub 2024 Jun 10.
2
Invasive Group G Streptococcal Infection Complicated by Posterior Reversible Encephalopathy Syndrome: A Case Report.
Am J Case Rep. 2023 Nov 28;24:e942206. doi: 10.12659/AJCR.942206.
3
Venoarterial extracorporeal membrane oxygenation for group B streptococcal toxic shock syndrome: A case report and literature review.
Medicine (Baltimore). 2023 Sep 15;102(37):e34680. doi: 10.1097/MD.0000000000034680.
4
Toxic shock syndrome complicated with symmetrical peripheral gangrene after liposuction and fat transfer: a case report and literature review.
BMC Infect Dis. 2021 Nov 6;21(1):1137. doi: 10.1186/s12879-021-06777-2.
5
Clinical Characteristics of Necrotizing Soft Tissue Infection and Early Toxic Shock-Like Syndrome Caused by Group G : Case Report and Review of Literature.
Kans J Med. 2021 Jun 21;14(2):158-161. doi: 10.17161/kjm.vol1415038. eCollection 2021.
6
Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review.
Cureus. 2021 Jan 21;13(1):e12836. doi: 10.7759/cureus.12836.
7
Myalgia, Obtundity and Fever in a Patient with a Prosthesis.
Eur J Case Rep Intern Med. 2019 Feb 8;6(2):001021. doi: 10.12890/2019_001021. eCollection 2019.
8
Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.
PLoS One. 2019 Mar 7;14(3):e0211786. doi: 10.1371/journal.pone.0211786. eCollection 2019.
9
Multifocal septic arthritis, gluteal abscess and spondylodiscitis by subspecies after an intramuscular injection.
BMJ Case Rep. 2017 Jul 19;2017:bcr-2017-220336. doi: 10.1136/bcr-2017-220336.
本文引用的文献
1
Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Clin Infect Dis. 2014 Sep 15;59(6):851-7. doi: 10.1093/cid/ciu449. Epub 2014 Jun 13.
2
A fatal case of streptococcal toxic shock syndrome due to Streptococcus dysgalactiae subsp. equisimilis possibly caused by an intramuscular injection.
Intern Med. 2013;52(3):397-402. doi: 10.2169/internalmedicine.52.8846. Epub 2013 Feb 1.
3
A case of streptococcal toxic shock syndrome due to Group G streptococci identified as Streptococcus dysgalactiae subsp. equisimilis.
J Infect Chemother. 2012 Dec;18(6):919-24. doi: 10.1007/s10156-012-0375-x. Epub 2012 Feb 11.
4
Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS).
BMC Genomics. 2011 Jan 11;12:17. doi: 10.1186/1471-2164-12-17.
5
Molecular epidemiological investigation of an outbreak of invasive beta-haemolytic streptococcal infection in western Norway.
Clin Microbiol Infect. 2009 Mar;15(3):245-52. doi: 10.1111/j.1469-0691.2008.02664.x. Epub 2009 Jan 28.
6
Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alpha-haemolytic Streptococcus dysgalactiae subsp. equisimilis.
J Med Microbiol. 2006 Jul;55(Pt 7):953-956. doi: 10.1099/jmm.0.46507-0.
7
Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome.
J Clin Microbiol. 2004 Jan;42(1):186-92. doi: 10.1128/JCM.42.1.186-192.2004.
8
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.
Clin Infect Dis. 2003 Aug 1;37(3):333-40. doi: 10.1086/376630. Epub 2003 Jul 17.
9
Serum cytokine level during continuous venovenous hemofiltration in toxic shock-like syndrome due to group G beta Streptococcus bacteremia in a patient with idiopathic thrombocytopenic purpura.
Scand J Infect Dis. 2002;34(6):403-6. doi: 10.1080/00365540110080683.
10
Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK.
Clin Microbiol Infect. 2002 Mar;8(3):174-81. doi: 10.1046/j.1469-0691.2002.00396.x.
Zotero 插件